📰 Cara News
Page 60 - Cara News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cara. Real-time updates on events, politics, business and more.
March 15, 2022
As the lodging industry struggles to recover from the pandemic, Proper Hospitality has opened a luxury inn in a historic downtown L.A. building. One suite features a pool big enough to swim laps.
March 12, 2022
The landscapes of the Sonoran Desert inform the inviting, modern F&B concept, designed by Celano Design Studio.
March 10, 2022
A number of firms have modified their ratings and price targets on shares of Cara Therapeutics (NASDAQ: CARA) recently: 3/8/2022 – Cara Therapeutics was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $20.00 price target on the stock, up previously from $17.00. 3/4/2022 […]
March 8, 2022
Sheraton Phoenix Downtown will unveil the highly-anticipated Caracara restaurant as one of the final phases of a property-wide renovation.
March 5, 2022
StockNews.com cut shares of Cara Therapeutics (NASDAQ:CARA – Get Rating) from a hold rating to a sell rating in a research note issued to investors on Friday. Other equities analysts also recently issued reports about the company. Zacks Investment Research downgraded Cara Therapeutics from a strong-buy rating to a hold rating in a research note […]
March 5, 2022
Bombshell is the Women’s History Month special edition IPA that’s about to take the local craft beer industry by storm. “We got together as women-owned...
March 5, 2022
Articles from the tag: craft brewers
March 4, 2022
Cara Therapeutics (NASDAQ:CARA – Get Rating) released its earnings results on Tuesday. The biopharmaceutical company reported ($0.63) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.50) by ($0.13), MarketWatch Earnings reports. During the same period last year, the company earned $1.59 earnings per share. CARA opened at $11.08 on Friday. The stock’s […]
March 4, 2022
Cara Therapeutics (NASDAQ:CARA – Get Rating) issued its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.63) EPS for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.13), MarketWatch Earnings reports. During the same quarter in the prior year, the business earned $1.59 earnings per share. Shares of NASDAQ CARA opened at $11.08 […]
March 1, 2022
Organic grower anticipates strong volumes of organic specialty citrus through April